Abdullah Balhamar Selected Research

Abdullah Balhamar Research Topics

8	COVID-19 01/2022 - 01/2020
4	Pulmonary Embolism 01/2022 - 01/2020
4	Lymphopenia (Lymphocytopenia) 09/2021 - 01/2020
4	Critical Illness (Critically Ill) 05/2021 - 01/2021
2	Infections 01/2022 - 01/2021
2	Sepsis (Septicemia) 05/2021 - 03/2021
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 05/2021 - 01/2020
1	Cytokine Release Syndrome 05/2021
1	Shock 05/2021
1	Acute Kidney Injury (Acute Renal Failure) 05/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021
1	Cardiac Arrhythmias (Arrythmia) 01/2021
1	Thromboembolism 01/2021
1	Severe Acute Respiratory Syndrome 01/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2020
1	Kidney Diseases (Kidney Disease) 01/2020
1	Bronchiectasis 01/2020
1	Brain Infarction 01/2020
1	Stroke (Strokes) 01/2020
1	Coinfection 01/2020
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020

3	fibrin fragment D (D-dimer)IBA 01/2022 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 05/2021
2	Lactic Acid (Lactate)FDA LinkGeneric 09/2021 - 01/2021
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2021 - 01/2020
1	Biomarkers (Surrogate Marker)IBA 05/2021
1	Oxygen (Dioxygen)IBA 03/2021
1	tetraethylpyrazine (TEP)IBA 01/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2020
1	Fibrinogen (Factor I)FDA Link 01/2020
1	Ferritins (Ferritin)IBA 01/2020
1	SteroidsIBA 01/2020
1	Doxycycline (Periostat)FDA LinkGeneric 01/2020
1	AnticoagulantsIBA 01/2020
1	Vitamin D FDA LinkGeneric 01/2020
1	Cholecalciferol (Vitamin D3)FDA Link 01/2020
1	C-Reactive ProteinIBA 01/2020
1	Antiphospholipid AntibodiesIBA 01/2020
1	BilirubinIBA 01/2020
1	acid citrate dextroseIBA 01/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020

4	Therapeutics 05/2021 - 01/2020
2	Plasma Exchange 05/2021 - 01/2020
1	Continuous Renal Replacement Therapy 05/2021
1	Renal Dialysis (Hemodialysis) 01/2020
1	Blood Component Removal (Apheresis) 01/2020